Catalyst Wire Dossier Catalyst Wire Dossier

Quadrivalent influenza virus subunit vaccine

Quadrivalent influenza virus subunit vaccine · Ab&B Bio-tech Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Quadrivalent influenza virus subunit vaccine, covering 2026-01-02 to 2026-01-02. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 Months [Phase 3]

See pricing